| scholarly article | Q13442814 |
| P2093 | author name string | Lidao Bao | |
| Ruilian Ma | |||
| Xianhua Ren | |||
| Hongmei Gan | |||
| Haijun Lv | |||
| Y I Wang | |||
| Guomin Wei | |||
| P2860 | cites work | Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus | Q42652239 |
| Varicella-zoster virus in children immunized with the varicella vaccine | Q43521755 | ||
| Comparison of the immune responses in BALB/c mice following immunization with DNA-based and live attenuated vaccines delivered via different routes | Q44280820 | ||
| Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice | Q45359726 | ||
| Sequence analysis of the glycoprotein E gene of varicella-zoster virus strains of clades 1, 3 and 5 | Q45370931 | ||
| [Construction and identification of recombinant eukaryotic plasmid pcDNA3.1(+)-ECH1] | Q84560077 | ||
| Construction and analysis of experimental DNA vaccines against megalocytivirus | Q84982569 | ||
| Immunisation of mice with Mycoplasma hyopneumoniae antigens P37, P42, P46 and P95 delivered as recombinant subunit or DNA vaccines | Q85396240 | ||
| Improving the safety of viral DNA vaccines: development of vectors containing both 5' and 3' homologous regulatory sequences from non-viral origin | Q87353725 | ||
| The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection | Q33554456 | ||
| Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection | Q33591823 | ||
| Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis | Q34457924 | ||
| Seroepidemiologic survey of varicella-zoster virus in korean adults using glycoprotein enzyme immuno assay and fluorescent antibody to membrane antigen test | Q35059642 | ||
| Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells | Q35076854 | ||
| Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1. | Q35138748 | ||
| Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation | Q35314247 | ||
| Transgenic carrot expressing fusion protein comprising M. tuberculosis antigens induces immune response in mice | Q35530615 | ||
| Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor | Q35628183 | ||
| Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D | Q36423681 | ||
| The future of human DNA vaccines | Q36438236 | ||
| Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice | Q36541588 | ||
| Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins | Q36606717 | ||
| Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus. | Q36694825 | ||
| Harnessing DNA-induced immune responses for improving cancer vaccines. | Q36694866 | ||
| Non-contact helium-based plasma for delivery of DNA vaccines. Enhancement of humoral and cellular immune responses | Q36694887 | ||
| An attenuated Listeria monocytogenes vector primes more potent simian immunodeficiency virus-specific mucosal immunity than DNA vaccines in mice | Q36760205 | ||
| Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry | Q37033241 | ||
| Surface markers of lymphocyte activation and markers of cell proliferation | Q37961573 | ||
| Current trends in separation of plasmid DNA vaccines: a review | Q38069666 | ||
| Sialic Acids on Varicella-Zoster Virus Glycoprotein B Are Required for Cell-Cell Fusion | Q38860689 | ||
| Construction and evaluation of DNA vaccine encoding Hantavirus glycoprotein N-terminal fused with lysosome-associated membrane protein | Q39001093 | ||
| Three types of human CpG motifs differentially modulate and augment immunogenicity of nonviral and viral replicon DNA vaccines as built-in adjuvants | Q39265708 | ||
| Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology | Q39548825 | ||
| Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors. | Q39998958 | ||
| Targeted Microbubbles for Ultrasound Mediated Short Hairpin RNA Plasmid Transfection to Inhibit Survivin Gene Expression and Induce Apoptosis of Ovarian Cancer A2780/DDP Cells | Q41545706 | ||
| Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells | Q41648531 | ||
| Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection | Q41758077 | ||
| Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood | Q41834312 | ||
| P433 | issue | 5 | |
| P921 | main subject | environmental DNA | Q25098939 |
| P304 | page(s) | 1788-1794 | |
| P577 | publication date | 2016-02-19 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | Immunogenicity of varicella zoster virus glycoprotein E DNA vaccine | |
| P478 | volume | 11 |
Search more.